
Perspectives on Enquiry & Evidence
Cytel's blog featuring the latest industry insights.

March 6, 2018
Photo by Dose Media on Unsplash By Charles Liu, Senior Product Manager, Cytel Several years ago, I was one of few...
Read article

January 26, 2018
6 Innovative Trial Design Videos
The Cytel YouTube Channel hosts a wealth of video presentations from Cytel experts as well as external industry and...
Read article

September 29, 2016
Case studies:Learning from less-well understood adaptive designs
A paper "Best practices case studies for 'less well-understood' Adaptive designs", has been published by the DIA...
Read article
September 9, 2016
Case Study:Seamless Phase 2/3 Design in Rare Disease
Challenge: Our client, an emerging biotechnology company, was preparing for the next stage of development for their...
Read article

August 31, 2016
An Introduction to BLRM
Traditional rule-based approaches to dose escalation such as 3+3 are widely used in early clinical development. They...
Read article

July 21, 2016
Webinar Replay: Single and Double Agent Dose Escalation Designs
Did you miss our webinar on Single and Dual Agent Dose escalation designs earlier in the year? In this blog we have...
Read article

July 5, 2016
PROC MCPMod in Bronchodilator Case Study
At a recent PhUSE SDE, Cytel’s Chitra Tirodkar presented how East PROC MCPMod could be used to help solve the problem...
Read article

June 16, 2016
Determining the future course of your trial
Predicting the course of a clinical trial is something which people will always want to do-whether for statistical...
Read article

May 31, 2016
EAST 6.4 Release: Interview with Yannis Jemiai
Last week, we were delighted to announce the release of East 6.4 bringing further cutting –edge approaches to the East...
Read article

March 11, 2016
EAST takes on Multi-Arm Multi-Stage Designs
There has been increasing interest in multi-arm multi-stage trials with treatment selection and sample size...
Read article

May 8, 2014
5 Reasons to Invest in Bayesian Dose-Escalation Methods
( Editor's note: This post has been refreshed in December 2016) Model based algorithms for Phase I dose-escalation have...
Read article